SD HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
NASH Race Has Room For Multiple Winners
BIOTECH: Five S.D. Cos. Trying for Liver TherapeuticIt’s a market forecast to reach upward of $35 billion. And it’s untapped — for now.Viking’s Stock Climbs Following Competitor’s NASH Results
Viking Therapeutics’ stock has climbed after another company’s disappointing results in the first late-stage clinical trial of a fatty liver disease.
Special Report: Life Science Firms Show Increased Interest In North County
BIOTECH: Why Pay More Is One Company’s Philosophy
When Ionis Pharmaceuticals was looking for a new home, it chose Carlsbad over the more traditional sites for life science companies in central San Diego County.
Boutique CROs Find Themselves in Demand
BIOTECH: M&A in the Air at Contract Research Organizations
A crop of San Diego companies quietly play niche roles in drug development. But suitors have taken notice.
Dexcom Reports 53% Increase in Q4 Revenue
Dexcom in fourth quarter financials reported that revenue shot up 53 percent year-over-year to $338 million.
Connect CEO Leaves for a New Venture
Connect CEO Greg McKee is leaving the San Diego accelerator to co-found Torrent Ventures.
ResMed, Fisher & Paykel Settle Patent Infringement Litigation
A wide-ranging patent dispute between San Diego-based ResMed and Fisher & Paykel Healthcare has come to an end.
NuVasive Reports Q4 Results
NuVasive reported net income of $12.2 million, or $0.23 per share, in fourth quarter results.
Tourism & Hospitality: Cannabiniers Wants Piece Of The Pie
According to The State of Legal Marijuana Markets report, released mid-2018 by Arcview Market Research and BDS Analytics, the legal cannabis business in the United States is projected to be a $23 billion industry by 2022. And, Little Italy-headquartered Cannabiniers, a cannabis brand management company, wants a piece of the pie.
Scripps, UC San Diego Health Land Opioid Treatment Grants
Scripps Mercy Hospital San Diego landed a $260,000 grant for opioid disorder treatment, the California Bridge Program recently announced.
Cellular Aquaculture Co. Seeks to ‘Grow’ Seafood
ENVIRONMENT: BlueNalu Puts A Biotech Twist on Catching Dinner
To satisfy the world’s growing appetite for seafood, one San Diego company is exploring laboratories rather than the ocean.
Amplyx Pharmaceuticals Snags FDA Orphan Drug Designation
San Diego-based Amplyx Pharmaceuticals’ lead drug candidate received an orphan drug designation for a condition that can be life-threatening for HIV/AIDs patients and others.
Special Report: An In-Demand Address
REAL ESTATE: Raw Land Scarce, Reuse Eyed in North County
Despite the shrinking inventory of raw land, demand for North County property is going strong, with low vacancy rates for industrial and office property.
AMN Healthcare Reports Fourth Quarter Results
AMN Healthcare recently reported $529 million in fourth quarter revenue, a 4 percent year-over-year increase. San Diego-based AMN is the country’s largest health care staffing agency.
LIfe Sciences: Analysts Skeptical of Smith & Nephew Acquiring NuVasive
A recent report stated that Smith & Nephew Plc has held talks to buy San Diego spine surgery company NuVasive. But analysts largely said the deal doesn’t make sense for the British firm.
Life Sciences: Oncology Conference Puts Ideas Into Action
The 350 attendees are proven men and women of action.
Prev Next